Table 2.
γ-Tocopherol Quartiles (μg/mL) | Median (μg/mL) | Participants (N) | Deaths (N) | HR (95% CI)a | Ptrenda |
---|---|---|---|---|---|
Men | |||||
Model 1b | |||||
Q1 (0.27–1.17) | 0.96 | 973 | 198 | 1.00 | |
Q2 (1.17–1.63) | 1.39 | 974 | 211 | 1.18 (0.97–1.43) | |
Q3 (1.63–2.28) | 1.92 | 968 | 223 | 1.25 (1.02–1.52) | |
Q4 (2.28–11.02) | 2.86 | 972 | 237 | 1.43 (1.17–1.74) | 0.0005 |
Model 2c | |||||
Q1 (0.27–1.17) | 0.96 | 971 | 192 | 1.00 | |
Q2 (1.17–1.63) | 1.39 | 968 | 209 | 1.12 (0.92–1.38) | |
Q3 (1.63–2.28) | 1.92 | 960 | 220 | 1.23 (1.00–1.50) | |
Q4 (2.28–11.02) | 2.86 | 963 | 235 | 1.15 (0.93–1.41) | 0.23 |
Model 3d | |||||
Q1 (0.27–1.17) | 0.96 | 973 | 198 | 1.00 | |
Q2 (1.17–1.63) | 1.39 | 974 | 211 | 1.16 (0.96–1.42) | |
Q3 (1.63–2.28) | 1.92 | 968 | 223 | 1.23 (1.01–1.49) | |
Q4 (2.28–11.02) | 2.86 | 972 | 237 | 1.34 (1.09–1.63) | 0.006 |
Women | |||||
Model 1b | |||||
Q1 (0–1.17) | 0.97 | 1113 | 136 | 1.00 | |
Q2 (1.17–1.66) | 1.40 | 1112 | 139 | 1.06 (0.84–1.35) | |
Q3 (1.66–2.39) | 1.98 | 1114 | 138 | 1.11 (0.87–1.41) | |
Q4 (2.39–13.97) | 2.98 | 1113 | 181 | 1.58 (1.25–2.00) | <0.0001 |
Model 2c | |||||
Q1 (0–1.17) | 0.97 | 1110 | 136 | 1.00 | |
Q2 (1.17–1.66) | 1.40 | 1106 | 139 | 1.03 (0.81–1.32) | |
Q3 (1.66–2.39) | 1.98 | 1101 | 137 | 1.04 (0.82–1.34) | |
Q4 (2.39–13.97) | 2.98 | 1110 | 179 | 1.38 (1.08–1.75) | 0.005 |
Model 3d | |||||
Q1 (0–1.17) | 0.97 | 1113 | 136 | 1.00 | |
Q2 (1.17–1.66) | 1.40 | 1112 | 139 | 1.07 (0.85–1.37) | |
Q3 (1.66–2.39) | 1.98 | 1114 | 138 | 1.07 (0.84–1.36) | |
Q4 (2.39–13.97) | 2.98 | 1113 | 181 | 1.45 (1.14–1.83) | 0.001 |
HR, 95% CI and P values were estimated by Cox proportional hazards models.
Model 1: Adjusted by Cox regression for age at blood draw, race/ethnicity (as a strata variable) and serum cholesterol levels.
Model 2: Adjusted by Cox regression for variables in Model 1, and further adjusted for history of cancer, cardiovascular diseases, diabetes, and hypertension and smoking related variables.
Model 3: Adjusted by Cox regression for variables in Model 1, and further adjusted for C-reactive protein (log-transformed).